表紙
市場調查報告書

生命科學領域的分析的市場: ∼2021年:各類型 (描述性、處方性分析)、用途 (行銷、R&D、法規遵守、SCM)、零組件 (軟體、服務)、遞送、終端用戶

Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery (On Premise, Cloud), End User - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 424447
出版日期 內容資訊 英文 167 Pages
訂單完成後即時交付
價格
Back to Top
生命科學領域的分析的市場: ∼2021年:各類型 (描述性、處方性分析)、用途 (行銷、R&D、法規遵守、SCM)、零組件 (軟體、服務)、遞送、終端用戶 Life Science Analytics Market by Type (Predictive, Descriptive, Prescriptive), Application (Marketing, Compliance, R&D, Pharmacovigilance, SCM), Component (Software, Service), Delivery (On Premise, Cloud), End User - Global Forecast to 2024
出版日期: 2019年07月05日內容資訊: 英文 167 Pages
簡介

全球生命科學領域的分析的市場預計從2016年到2021年以13.3%的年複合成長率發展,從2016年的132億6000萬美元,成長到2021年的247億3000萬美元的規模。技術的進步和巨量資料的可用性,臨床試驗和銷售&行銷部門的分析解決方案的引進擴大,對資料的標準化的需求高漲等的要素促進該市場的成長。

本報告提供生命科學領域的分析的市場調查,市場及解決方案概要,市場成長的各種影響因素與市場機會分析,各用途、零組件、傳輸模式、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查方法

第3章 摘要整理

第4章 重要考察

  • 市場概要
  • 各類型市場
  • 各用途市場
  • 各零件市場
  • 各傳輸模式市場
  • 各終端用戶市場
  • 地區概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進成長要素
    • 阻礙成長要素
    • 市場機會
    • 課題

第6章 市場分析:各類型

  • 簡介
  • 描述性分析
  • 預測的分析
  • 處方性分析

第7章 市場分析:各用途

  • 簡介
  • R&D
    • 臨床試驗前
    • 臨床試驗
  • 銷售、行銷支援
  • 法規遵守
  • 供應鏈分析
  • 藥物安全檢測

第8章 市場分析:各零件

  • 簡介
  • 服務
  • 軟體

第9章 市場分析:各傳輸模式

  • 簡介
  • 內部部署
  • 隨選

第10章 市場分析:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 醫療設備企業
  • 研究中心
  • 第三方

第11章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 亞洲
  • 其他地區

第12章 競爭環境

  • 概要
  • 市場分析
  • 競爭情形、趨勢
    • 產品與服務的投入、升級、強化
    • 聯盟、協定、合作
    • 擴張
    • M&A

第13章 企業簡介

  • 簡介
  • SAS INSTITUTE INC.
  • IBM CORPORATION
  • ORACLE CORPORATION
  • QUINTILES, INC.
  • ACCENTURE
  • COGNIZANT
  • MAXISIT
  • SCIO HEALTH ANALYTICS
  • TAKE SOLUTIONS
  • WIPRO LIMITED
    • 簡介
    • 產品與服務
    • 策略
    • 分析師的見解等

第14章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HIT 4869

"Technological advancements, the need for improved data standardization, and the growing adoption of analytics solutions in clinical trials are the key factors driving the life science analytics market."

The life science analytics market is projected to reach USD 33.2 billion by 2024 from USD 19.3 billion in 2019, at a CAGR of 11.5% during the forecast period. Growth in this market is mainly driven by technological advancements, big data in the life science industry, growing adoption of analytics solutions in clinical trials, increasing adoption of analytics for sales and marketing applications, need for improved data standardization, increasing prevalence of chronic diseases, and growing pressure to curb healthcare spending. On the other hand, high implementation costs are expected to restrain the growth of this market to a certain extent

"Prescriptive analytics segment to grow at the highest CAGR during the forecast period."

Based on type, the life science analytics market is segmented into descriptive, predictive, and prescriptive analytics. The descriptive analytics segment accounted for the largest share of the life science analytics market in 2018, while the prescriptive analytics segment is projected to grow at the highest CAGR during the forecast period due to its ability to ensure the synergistic integration of predictions and prescriptions.

"Services segment accounted for the largest share of the life science analytics market in 2019."

On the basis of component, the life science analytics market is segmented into services and software. The services segment accounted for the largest market share in 2018 and is expected to register the highest growth during the forecast period. The large share and high growth in this segment can be attributed to the recurring need for services such as software upgrades and maintenance.

"Asia to be the fastest-growing regional market."

By region, the life science analytics market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America accounted for the largest market share in 2018. The large share of this market is attributed to the strong economies in the US and Canada, which have allowed for significant investments in technology in this region. However, Asia is expected to grow at the highest CAGR during the forecast period. Factors such as growing R&D investments, increase in drug development-based research, rising pressure to comply with regulatory requirements, and low manufacturing costs in the region are supporting the growth of the life science analytics market in Asia.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (32%), Tier 2 (44%), and Tier 3 (24%)
  • By Designation: C-level (30%), D-level (34%), and Others (36%)
  • By Region: North America (40%), Europe (28%), Asia (20%), and the RoW (12%)

List of Companies Profiled in the Report:

  • IBM Corporation (US)
  • SAS Institute, Inc. (US)
  • Oracle Corporation (US)
  • Quintiles, Inc. (US)
  • Accenture (Ireland)
  • Cognizant (US)
  • Wipro Limited (India)
  • MaxisIT Inc. (US)
  • TAKE Solutions (India)
  • SCIO Health Analytics (US)

Research Coverage:

This report provides a picture of the life science analytics market. It aims at estimating the size and future growth potential of the market across different segments, such as type, component, deployment model, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall life science analytics market and its subsegments. This report will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY SOURCES
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY SOURCES
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. LIFE SCIENCE ANALYTICS MARKET OVERVIEW
  • 4.2. LIFE SCIENCE ANALYTICS MARKET, BY TYPE
  • 4.3. LIFE SCIENCE ANALYTICS MARKET, BY END USER
  • 4.4. GEOGRAPHIC SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. DRIVERS
      • 5.1.1.1. Technological advancements
      • 5.1.1.2. Big data in the life science industry
      • 5.1.1.3. Growing adoption of analytics solutions in clinical trials
      • 5.1.1.4. Increasing adoption of analytics for sales and marketing applications
      • 5.1.1.5. Need for improved data standardization
      • 5.1.1.6. Increasing prevalence of chronic diseases
      • 5.1.1.7. Growing pressure to curb healthcare spending and the need for improved patient outcomes
    • 5.1.2. RESTRAINTS
      • 5.1.2.1. High implementation costs
    • 5.1.3. OPPORTUNITIES
      • 5.1.3.1. Increasing focus on value-based medicine
      • 5.1.3.2. Use of analytics in precision and personalized medicine
      • 5.1.3.3. Use of big data analytics to increase R&D productivity
      • 5.1.3.4. Emergence of social media and its impact on the life science industry
    • 5.1.4. CHALLENGES
      • 5.1.4.1. Data privacy issues
      • 5.1.4.2. Data integration in the life science ecosystem
      • 5.1.4.3. Dearth of skilled personnel

6. LIFE SCIENCE ANALYTICS MARKET, BY TYPE

  • 6.1. INTRODUCTION
  • 6.2. DESCRIPTIVE ANALYTICS
    • 6.2.1. DESCRIPTIVE ANALYTICS SEGMENT TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET
  • 6.3. PREDICTIVE ANALYTICS
    • 6.3.1. PREDICTIVE ANALYTICS SOLUTIONS CAN HELP INCREASE THE ACCURACY OF DATA
  • 6.4. PRESCRIPTIVE ANALYTICS
    • 6.4.1. PRESCRIPTIVE ANALYTICS SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD

7. LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RESEARCH & DEVELOPMENT
    • 7.2.1. CLINICAL TRIALS
      • 7.2.1.1. Need to streamline clinical trials and reduce the time and cost of drug development to drive the demand for analytics solutions
    • 7.2.2. PRECLINICAL TRIALS
      • 7.2.2.1. Analytics solutions for preclinical trials help in the entire discovery and research value chain
  • 7.3. SALES & MARKETING
    • 7.3.1. SALES & MARKETING ANALYTICS ARE ESSENTIAL TO INCREASE REVENUE AND PROFITABILITY
  • 7.4. PHARMACOVIGILANCE
    • 7.4.1. PLAYERS OPERATING IN THIS SEGMENT ARE INCREASINGLY FOCUSING ON NEW PRODUCT LAUNCHES
  • 7.5. REGULATORY COMPLIANCE
    • 7.5.1. STRINGENT REQUIREMENTS HAVE SUPPORTED THE NEED FOR COMPLIANCE ADHERENCE SOLUTIONS
  • 7.6. SUPPLY CHAIN OPTIMIZATION
    • 7.6.1. GROWING NEED TO REDUCE LOGISTICS COSTS TO DRIVE THE ADOPTION OF ANALYTICS SOLUTIONS

8. LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT

  • 8.1. INTRODUCTION
  • 8.2. SERVICES
    • 8.2.1. SERVICES FORM A LARGER COMPONENT OF THE LIFE SCIENCE ANALYTICS MARKET
  • 8.3. SOFTWARE
    • 8.3.1. LIFE SCIENCE ANALYTICS SOFTWARE SOLUTIONS ENABLE PHARMA-BIOTECH COMPANIES AND MEDICAL DEVICE COMPANIES TO MANAGE CLINICAL TRIALS DATA AND PROVIDE SALES AND MARKETING SUPPORT

9. LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL

  • 9.1. INTRODUCTION
  • 9.2. ON-PREMISE DELIVERY MODEL
    • 9.2.1. ON-PREMISE SOLUTIONS OFFER MULTIVENDOR ARCHITECTURE, WHICH LOWERS THE RISK OF DATA BREACHES & EXTERNAL ATTACKS
  • 9.3. ON-DEMAND DELIVERY MODEL
    • 9.3.1. INCREASING VOLUME OF DATA GENERATED ACROSS THE LIFE SCIENCE INDUSTRY WILL DRIVE THE ADOPTION OF ON-DEMAND SOLUTIONS

10. LIFE SCIENCE ANALYTICS MARKET, BY END USER

  • 10.1. INTRODUCTION
  • 10.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
    • 10.2.1. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES SEGMENT TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • 10.3. MEDICAL DEVICE COMPANIES
    • 10.3.1. ADOPTION OF BIG DATA ANALYTICS IS HELPING MEDICAL DEVICE MANUFACTURERS TO SECURE A COMPETITIVE ADVANTAGE IN THE INDUSTRY
  • 10.4. RESEARCH CENTERS
    • 10.4.1. INCREASING RESEARCH ACTIVITIES TO DRIVE THE ADOPTION OF ANALYTICS SOLUTIONS IN THIS END-USER SEGMENT
  • 10.5. THIRD-PARTY ADMINISTRATORS
    • 10.5.1. RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE THE GROWTH OF THIS END-USER SEGMENT

11. LIFE SCIENCE ANALYTICS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. US
      • 11.2.1.1. Strong economy and increasing R&D expenditure are expected to drive the growth of the life science analytics market in the US
    • 11.2.2. CANADA
      • 11.2.2.1. Rising need for data standardization in the life science industry to support market growth in Canada
  • 11.3. EUROPE
    • 11.3.1. GERMANY
      • 11.3.1.1. Growing R&D investments by pharmaceutical and biotechnology companies to drive market growth in Germany
    • 11.3.2. FRANCE
      • 11.3.2.1. Growing government support for the adoption of AI and big data analytics to drive market growth in France
    • 11.3.3. UK
      • 11.3.3.1. UK to dominate the European life science analytics market during the forecast period
    • 11.3.4. REST OF EUROPE
  • 11.4. ASIA
    • 11.4.1. JAPAN
      • 11.4.1.1. Growing government support for clinical R&D activities to drive the demand for analytics solutions in Japan
    • 11.4.2. CHINA
      • 11.4.2.1. Growth of the life science industry to drive market growth in China
    • 11.4.3. INDIA
      • 11.4.3.1. Rising R&D budgets and growing number of drug development-based research activities to support market growth in India
    • 11.4.4. REST OF ASIA
  • 11.5. REST OF THE WORLD

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET PLAYER RANKING
  • 12.3. COMPETITIVE LEADERSHIP MAPPING-OVERALL MARKET
    • 12.3.1. VISIONARY LEADERS
    • 12.3.2. DYNAMIC DIFFERENTIATORS
    • 12.3.3. INNOVATORS
    • 12.3.4. EMERGING PLAYERS
  • 12.4. COMPETITIVE SITUATION AND TRENDS
    • 12.4.1. PRODUCT LAUNCHES
    • 12.4.2. EXPANSIONS
    • 12.4.3. ACQUISITIONS
    • 12.4.4. AGREEMENTS, PARTNERSHIPS, AND COLLABORATION

13. COMPANY PROFILES (Business Overview, Products Offered, Recent Developments, MnM View)*

  • 13.1. SAS INSTITUTE INC.
  • 13.2. IBM CORPORATION
  • 13.3. ORACLE CORPORATION
  • 13.4. IQVIA
  • 13.5. ACCENTURE
  • 13.6. COGNIZANT
  • 13.7. MAXISIT
  • 13.8. SCIO HEALTH ANALYTICS
  • 13.9. TAKE SOLUTIONS
  • 13.10. WIPRO LIMITED

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. DISCUSSION GUIDE
  • 14.2. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.3. AVAILABLE CUSTOMIZATIONS
  • 14.4. RELATED REPORTS
  • 14.5. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 2: DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 3: NORTH AMERICA: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 4: EUROPE: DESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 5: PREDICTIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 6: NORTH AMERICA: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 7: EUROPE: PREDICTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 9: NORTH AMERICA: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10: EUROPE: PRESCRIPTIVE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 11: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 12: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 13: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 14: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 15: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 17: NORTH AMERICA: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: EUROPE: CLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 19: PRECLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 20: NORTH AMERICA: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: EUROPE: PRECLINICAL TRIAL ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 23: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 24: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 26: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 28: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 29: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SUPPLY CHAIN OPTIMIZATION, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 35: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 39: NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 40: EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 42: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 43: NORTH AMERICA: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 44: EUROPE: ON-PREMISE LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45: ON-DEMAND SOLUTIONS OFFERED IN THE MARKET
  • TABLE 46: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 47: NORTH AMERICA: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 48: EUROPE: ON-DEMAND LIFE SCIENCE ANALYTICS SOLUTIONS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 49: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 50: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 51: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 52: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 53: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 54: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 55: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 56: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 60: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 61: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR THIRD-PARTY ADMINISTRATORS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 63: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 65: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 66: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 67: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 68: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 69: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 70: US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 71: US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 72: US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 73: US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 74: US: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 75: US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 76: CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 77: CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 78: CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 79: CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 80: CANADA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 81: CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 82: EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 83: EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 84: EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 85: EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 87: EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 88: EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 89: GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 91: GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 92: GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 93: GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 94: GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 95: FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 97: FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 98: FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 99: FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 100: FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 101: UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 103: UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 104: UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 105: UK: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 106: UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 107: ROE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 108: ROE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 109: ROE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 110: ROE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 111: ROE: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 112: ROE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 113: ASIA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 114: ASIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 115: ASIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 116: ASIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 117: ASIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 118: ASIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 119: ASIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 120: JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 122: JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 123: JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 124: JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 125: CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 126: CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 127: CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 128: CHINA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 129: CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 130: INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 131: INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 132: INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 133: INDIA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 134: INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 135: ROA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 136: ROA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 137: ROA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 138: ROA: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 139: ROA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 140: ROW: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 141: ROW: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 142: ROW: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 143: ROW: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2017-2024 (USD MILLION)
  • TABLE 144: ROW: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2017-2024 (USD MILLION)
  • TABLE 145: ROW: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 146: LIFE SCIENCE ANALYTICS MARKET PLAYER RANKING, 2018
  • TABLE 147: PRODUCT LAUNCHES, 2016-2019
  • TABLE 148: EXPANSIONS, 2016-2019
  • TABLE 149: ACQUISITIONS, 2015-2019
  • TABLE 150: OTHER STRATEGIES, 2015-2019

LIST OF FIGURES

  • FIGURE 1: LIFE SCIENCE ANALYTICS: MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS
  • FIGURE 4: BOTTOM-UP APPROACH
  • FIGURE 5: TOP-DOWN APPROACH
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2019 VS. 2024 (USD BILLION)
  • FIGURE 8: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2019 VS. 2024 (USD BILLION)
  • FIGURE 9: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2019 VS. 2024 (USD BILLION)
  • FIGURE 10: LIFE SCIENCE ANALYTICS MARKET, BY DELIVERY MODEL, 2019 VS. 2024 (USD BILLION)
  • FIGURE 11: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2019 VS. 2024 (USD BILLION)
  • FIGURE 12: GEOGRAPHICAL SNAPSHOT: LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 13: TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS ARE DRIVING MARKET GROWTH
  • FIGURE 14: DESCRIPTIVE ANALYTICS TO DOMINATE THE LIFE SCIENCE ANALYTICS MARKET IN 2019
  • FIGURE 15: NORTH AMERICA TO HOLD THE LARGEST SHARE OF THE LIFE SCIENCE ANALYTICS END-USER MARKET IN 2019
  • FIGURE 16: ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 17: LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 18: HEALTHCARE SPENDING AS A PERCENTAGE OF THE GDP, BY COUNTRY, 2017
  • FIGURE 19: NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 20: EUROPE: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 21: ASIA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 22: KEY GROWTH STRATEGIES ADOPTED BY PLAYERS IN THE LIFE SCIENCE ANALYTICS MARKET FROM 2016 TO OCTOBER 2019
  • FIGURE 23: COMPETITIVE LEADERSHIP MAPPING OF THE LIFE SCIENCE ANALYTICS MARKET OVERALL MARKET
  • FIGURE 24: COMPANY SNAPSHOT: SAS INSTITUTE INC. (2017)
  • FIGURE 25: COMPANY SNAPSHOT: IBM CORPORATION (2018)
  • FIGURE 26: COMPANY SNAPSHOT: ORACLE CORPORATION (2018)
  • FIGURE 27: COMPANY SNAPSHOT: IQVIA (2018)
  • FIGURE 28: COMPANY SNAPSHOT: ACCENTURE (2018)
  • FIGURE 29: COMPANY SNAPSHOT: COGNIZANT (2018)
  • FIGURE 30: COMPANY SNAPSHOT: TAKE SOLUTIONS (2016)
  • FIGURE 31: COMPANY SNAPSHOT: WIPRO LIMITED (2018)
Back to Top